Search for a doctor

Sandra M. Herrmann, M.D.

  1. Internist
  2. Nephrologist
Request an Appointment

Publications

  1. Barbir EB, Mohan A, Koirala P, Gutierrez LE, Giesen CD, Lieske JC, Herrmann SM. Biomarker Guided Infliximab Therapy for Immune Checkpoint Inhibitor-induced Acute Interstitial Nephritis. Nephrol Dial Transplant. 2024 Nov 8 Epub 2024 Nov 08
    View PubMed
  2. Barbir EB, Kitchlu A, Herrmann SM. Immune checkpoint inhibitor-associated nephritis-treatment standard. Nephrol Dial Transplant. 2024 Oct 30; 39 (11):1785-1798
    View PubMed
  3. Herrmann SM, Abudayyeh A, Gupta S, Gudsoorkar P, Klomjit N, Motwani SS, Karam S, Costa E Silva VT, Khalid SB, Anand S, Kala J, Leaf DE, Murakami N, Rashidi A, Wanchoo R, Kitchlu A. Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology. Kidney Int. 2024 Oct 24 [Epub ahead of print]
    View PubMed
  4. Gupta S, Green-Lingren O, Bhimaniya S, Krokhmal A, Jacene H, Ostermann M, Chicklore S, Sprangers B, Deroose CM, Herrmann SM, Wells SL, Kaunfer SA, Ortega JL, Garcia-Carro C, Bold M, Chen KL, Sise ME, Heidari P, Pak WLW, Lee MD, Beckerman P, Eshet Y, Hsu RK, Hernandez Pampaloni M, Rashidi A, Avril N, Donley V, Mithani Z, Kuker R, Awiwi MO, Wang MX, Shah SI, Weintraub MD, Schoder H, Chowdhury RB, Seethapathy H, Reynolds KL, Soler MJ, Abudayyeh A, Glezerman I, Leaf DE. F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor-associated acute kidney injury. J Clin Invest. 2024 Aug 8; 134 (18) Epub 2024 Aug 08
    View PubMed
  5. Kitchlu A, Silva VTCE, Anand S, Kala J, Abudayyeh A, Inker LA, Rosner MH, Karam S, Gudsoorkar P, Gupta S, Chen S, Klomjit N, Leung N, Milanez T, Motwani SS, Khalid SB, Srinivasan V, Wanchoo R, Beumer JH, Liu G, Tannir NM, Orchanian-Cheff A, Geng Y, Herrmann SM. Assessment of GFR in Patients with Cancer: A Statement from the American Society of Onco-Nephrology. Clin J Am Soc Nephrol. 2024 Aug 1; 19 (8):1061-1072 Epub 2024 June 07
    View PubMed
  6. Kitchlu A, Silva VTCE, Anand S, Kala J, Abudayyeh A, Inker LA, Rosner MH, Karam S, Gudsoorkar P, Gupta S, Chen S, Klomjit N, Leung N, Milanez T, Motwani SS, Khalid SB, Srinivasan V, Wanchoo R, Beumer JH, Liu G, Tannir NM, Orchanian-Cheff A, Geng Y, Herrmann SM. Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies-Perspectives from the American Society of Onco-Nephrology (ASON). Clin J Am Soc Nephrol. 2024 Aug 1; 19 (8):1073-1077 Epub 2024 June 07
    View PubMed
  7. Miao J, Herrmann SM, Obaidi Z, Caza T, Bonilla M. Paraprotein-Mediated Glomerular Diseases. Adv Kidney Dis Health. 2024 Jul; 31 (4):358-373
    View PubMed
  8. Sohi GK, Farooqui N, Mohan A, Rajagopalan KS, Xing L, Zhu XY, Jordan K, Krier JD, Saadiq IM, Tang H, Hickson LJ, Eirin A, Lerman LO, Herrmann SM. The impact of hypoxia preconditioning on mesenchymal stem cells performance in hypertensive kidney disease. Stem Cell Res Ther. 2024 Jun 09; 15(1):162.
    View PubMed
  9. Truong HL, Barreto JN, Mara KC, Hampel PJ, Micallef IN, Nowakowski GS, Thanarajasingam G, Thompson CA, Wang Y, Witzig TE, Herrmann SM, Leung N. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma. JCO Oncol Pract. 2024 Jun; 20 (6):797-807 Epub 2024 Feb 26
    View PubMed
  10. Mohan A, Krisanapan P, Tangpanithandee S, Thongprayoon C, Kanduri SR, Cheungpasitporn W, Herrmann SM. Association of Proton Pump Inhibitor Use and Immune Checkpoint Inhibitor-Mediated Acute Kidney Injury: A Meta-Analysis and a Review of Related Outcomes. Am J Nephrol. 2024; 55 (4):439-449 Epub 2024 Mar 12
    View PubMed
  11. Pandey S, Kalaria A, Jhaveri KD, Herrmann SM, Kim AS. Management of hypertension in patients with cancer: challenges and considerations. Clin Kidney J. 2023 Dec; 16 (12):2336-2348 Epub 2023 Aug 12
    View PubMed
  12. Miao J, Herrmann SM. Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis. Clin Kidney J. 2023 Nov; 16 (11):1834-1844 Epub 2023 May 15
    View PubMed
  13. Sandoval L, Radhakrishnan Y, Vaughan LE, Potter A, Mansfield AS, Herrmann SM. Capmatinib-Associated Pseudoacute Kidney Injury in Nonsmall Cell Lung Cancer. Kidney Int Rep. 2023 Nov; 8 (11):2482-2485 Epub 2023 Aug 28
    View PubMed
  14. Kazeminia S, Zhu XY, Tang H, Jordan KL, Saadiq IM, Herrmann SM, Chade AR, Irazabal MV, Lerman LO, Eirin A. Renal ischemia alters the transcriptomic and epigenetic profile of inflammatory genes in swine scattered tubular-like cells. Clin Sci (Lond). 2023 Aug 31; 137 (16):1265-1283
    View PubMed
  15. Lees JS, Elyan BMP, Herrmann SM, Lang NN, Jones RJ, Mark PB. The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes. Nephrol Dial Transplant. 2023 May 4; 38 (5):1071-1079
    View PubMed
  16. Charkviani M, Herrmann SM. Immune Checkpoint Inhibitor-Associated Sarcoidosis Reaction in the Kidney: Case Report. Kidney Med. 2023 May; 5 (5):100626 Epub 2023 Mar 13
    View PubMed
  17. Butel-Simoes LE, Haw TJ, Williams T, Sritharan S, Gadre P, Herrmann SM, Herrmann J, Ngo DTM, Sverdlov AL. Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation. Hypertension. 2023 Apr; 80 (4):685-710 Epub 2023 Feb 09
    View PubMed
  18. Farooqui N, Zaidi M, Vaughan L, McKee TD, Ahsan E, Pavelko KD, Villasboas JC, Markovic S, Taner T, Leung N, Dong H, Alexander MP, Herrmann SM. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors. Kidney Int Rep. 2023 Mar; 8 (3):628-641 Epub 2022 Dec 05
    View PubMed
  19. Cohen JB, Brown NJ, Brown SA, Dent S, van Dorst DCH, Herrmann SM, Lang NN, Oudit GY, Touyz RM, American Heart Association Council on Hypertension; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on the Kidney in Cardiovascular Disease. Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association. Hypertension. 2023 Mar; 80 (3):e46-e57 Epub 2023 Jan 09
    View PubMed
  20. Bonilla M, Gudsoorkar P, Wanchoo R, Herrmann SM, Jhaveri KD. Onconephrology 2022: An Update. Kidney360. 2023 Feb 1; 4 (2):258-271 Epub 2022 Dec 09
    View PubMed
  21. Farooqui N, Mohan A, Isik B, Goksu BB, Thaler R, Zhu XY, Krier JD, Saadiq IM, Ferguson CM, Jordan KL, Tang H, Textor SC, Hickson TJ, van Wijnen AJ, Eirin A, Lerman LO, Herrmann SM. Effect of Hypoxia Preconditioning on the Regenerative Capacity of Adipose Tissue Derived Mesenchymal Stem Cells in a Model of Renal Artery Stenosis. Stem Cells. 2023 Jan 30; 41(1):50-63.
    View PubMed
  22. Sise ME, Wang Q, Seethapathy H, Moreno D, Harden D, Smith RN, Rosales IA, Colvin RB, Chute S, Cornell LD, Herrmann SM, Fadden R, Sullivan RJ, Yang NJ, Barmettler S, Wells S, Gupta S, Villani AC, Reynolds KL, Farmer J. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. J Immunother Cancer. 2023 Jan; 11 (1)
    View PubMed
  23. Seethapathy H, Herrmann SM, Rashidi A. Immune Checkpoint Inhibitor-Associated AKI: Debates in Diagnosis, Management, and Rechallenge. Semin Nephrol. 2022 Nov; 42 (6):151346 Epub 2023 May 01
    View PubMed
  24. Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME, ICPi-AKI Consortium. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney Int. 2022 Oct; 102 (4):930-935 Epub 2022 Aug 11
    View PubMed
  25. Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, Beckerman P, Renaghan AD, Carlos CA, Rashidi A, Mithani Z, Deshpande P, Rangarajan S, Shah CV, Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Ortiz-Melo DI, Sprangers B, Aggarwal V, Benesova K, Wanchoo R, Murakami N, Cortazar FB, Reynolds KL, Sise ME, Soler MJ, Leaf DE, ICPi-AKI Consortium Investigators. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI. J Immunother Cancer. 2022 Sep; 10 (9)
    View PubMed
  26. Farooqui N, Sy-Go JPT, Miao J, Mehta R, Vaughan LE, Bennani NN, Wang Y, Bansal R, Hathcock MA, Hayman SR, Johnston PB, Villasboas JC, Paludo J, Ansell SM, Leung N, Lin Y, Herrmann SM. Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy. Mayo Clin Proc. 2022 Jul; 97 (7):1294-1304
    View PubMed
  27. Rajagopalan KS, Glasstetter LM, Zhu XY, Thaler R, Tang H, Jordan KL, Saadiq IM, Herrmann SM, Chade AR, Irazabal MV, Lerman LO, Eirin A. Renal Ischemia Induces Epigenetic Changes in Apoptotic, Proteolytic, and Mitochondrial Genes in Swine Scattered Tubular-like Cells. Cells. 2022 May 31; 11 (11)
    View PubMed
  28. Herrmann SM. Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: PRO. Kidney360. 2022 May 26; 3 (5):799-802 Epub 2021 Sept 17
    View PubMed
  29. Gupta S, Caza T, Herrmann SM, Sakhiya VC, Jhaveri KD. Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors. Kidney Int Rep. 2022 Mar; 7 (3):618-623 Epub 2021 Dec 08
    View PubMed
  30. Sy-Go JPT, Herrmann SM, Seshan SV. Monoclonal Gammopathy-Related Kidney Diseases. Adv Chronic Kidney Dis. 2022 Mar; 29 (2):86-102.e1
    View PubMed
  31. Farahani RA, Yu S, Ferguson CM, Zhu XY, Tang H, Jordan KL, Saadiq IM, Herrmann SM, Chade AR, Lerman A, Lerman LO, Eirin A. Renal Revascularization Attenuates Myocardial Mitochondrial Damage and Improves Diastolic Function in Pigs with Metabolic Syndrome and Renovascular Hypertension. J Cardiovasc Transl Res. 2022 Feb; 15 (1):15-26 Epub 2021 July 16
    View PubMed
  32. Mohan A, Herrmann SM. Capmatinib-Induced Pseudo-Acute Kidney Injury: A Case Report. Am J Kidney Dis. 2022 Jan; 79(1):120-124. Epub 2021 Jun 09.
    View PubMed
  33. Miao J, Sise ME, Herrmann SM. Immune checkpoint inhibitor related nephrotoxicity: Advances in clinicopathologic features, noninvasive approaches, and therapeutic strategy and rechallenge. Front Nephrol. 2022; 2:1017921 Epub 2022 Oct 19
    View PubMed
  34. Seethapathy H, Herrmann SM, Sise ME. Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management. Kidney Med. 2021 Nov-Dec; 3 (6):1074-1081 Epub 2021 Oct 08
    View PubMed
  35. Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE, ICPi-AKI Consortium Investigators. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 Oct; 9 (10)
    View PubMed
  36. Alexander MP, Mangalaparthi KK, Madugundu AK, Moyer AM, Adam BA, Mengel M, Singh S, Herrmann SM, Rule AD, Cheek EH, Herrera Hernandez LP, Graham RP, Aleksandar D, Aubry MC, Roden AC, Hagen CE, Quinton RA, Bois MC, Lin PT, Maleszewski JJ, Cornell LD, Sethi S, Pavelko KD, Charlesworth J, Narasimhan R, Larsen CP, Rizza SA, Nasr SH, Grande JP, McKee TD, Badley AD, Pandey A, Taner T. Acute Kidney Injury in Severe COVID-19 Has Similarities to Sepsis-Associated Kidney Injury: A Multi-Omics Study. Mayo Clin Proc. 2021 Oct; 96 (10):2561-2575 Epub 2021 July 15
    View PubMed
  37. Hickson LJ, Abedalqader T, Ben-Bernard G, Mondy JM, Bian X, Conley SM, Zhu X, Herrmann SM, Kukla A, Lorenz EC, Kim SR, Thorsteinsdottir B, Lerman LO, Murad MH. A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease. Stem Cells Transl Med. 2021 Sep; 10 (9):1304-1319 Epub 2021 June 09
    View PubMed
  38. Hickson LJ, Eirin A, Conley SM, Taner T, Bian X, Saad A, Herrmann SM, Mehta RA, McKenzie TJ, Kellogg TA, Kirkland JL, Tchkonia T, Saadiq IM, Tang H, Jordan KL, Zhu X, Griffin MD, Rule AD, van Wijnen AJ, Textor SC, Lerman LO. Diabetic Kidney Disease Alters the Transcriptome and Function of Human Adipose-Derived Mesenchymal Stromal Cells but Maintains Immunomodulatory and Paracrine Activities Important for Renal Repair. Diabetes. 2021 Jul; 70 (7):1561-1574 Epub 2021 Apr 15
    View PubMed
  39. Qin H, Vlaminck B, Owoyemi I, Herrmann SM, Leung N, Markovic SN. Successful Treatment of Pembrolizumab-Induced Severe Capillary Leak Syndrome and Lymphatic Capillary Dysfunction. Mayo Clin Proc Innov Qual Outcomes. 2021 Jun; 5 (3):670-674 Epub 2021 June 07
    View PubMed
  40. Kanduri SR, Cheungpasitporn W, Thongprayoon C, Petnak T, Lin Y, Kovvuru K, Manohar S, Kashani K, Herrmann SM. Systematic Review of Risk factors and Incidence of Acute Kidney Injury Among Patients Treated with CAR-T Cell Therapies. Kidney Int Rep. 2021 May; 6 (5):1416-1422 Epub 2021 Feb 17
    View PubMed
  41. Isik B, Thaler R, Goksu BB, Conley SM, Al-Khafaji H, Mohan A, Afarideh M, Abumoawad AM, Zhu XY, Krier JD, Saadiq IM, Tang H, Eirin A, Hickson LJ, van Wijnen AJ, Textor SC, Lerman LO, Herrmann SM. Hypoxic preconditioning induces epigenetic changes and modifies swine mesenchymal stem cell angiogenesis and senescence in experimental atherosclerotic renal artery stenosis. Stem Cell Res Ther. 2021 Apr 14; 12(1):240.
    View PubMed
  42. van Dorst DCH, Dobbin SJH, Neves KB, Herrmann J, Herrmann SM, Versmissen J, Mathijssen RHJ, Danser AHJ, Lang NN. Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients. Circ Res. 2021 Apr 2; 128 (7):1040-1061 Epub 2021 Apr 01
    View PubMed
  43. Isik B, Alexander MP, Manohar S, Vaughan L, Kottschade L, Markovic S, Lieske J, Kukla A, Leung N, Herrmann SM. Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events. Kidney Int Rep. 2021 Apr; 6 (4):1022-1031 Epub 2021 Feb 02
    View PubMed
  44. Chengappa M, Herrmann S, Poonacha T. Self-reported Financial Conflict of Interest in Nephrology Clinical Practice Guidelines. Kidney Int Rep. 2021 Mar; 6 (3):768-774 Epub 2020 Dec 31
    View PubMed
  45. Hickson LJ, Herrmann SM, McNicholas BA, Griffin MD. Progress toward the Clinical Application of Mesenchymal Stromal Cells and Other Disease-Modulating Regenerative Therapies: Examples from the Field of Nephrology. Kidney360. 2021 Mar; 2 (3):542-557
    View PubMed
  46. Klomjit N, Shah K, Herrmann SM, Lieske JC. The Case | An unusual cause of tender skin lesion in an end-stage kidney disease patient. Kidney Int. 2021 Jan; 99 (1):275-276
    View PubMed
  47. Owoyemi I, Vaughan LE, Costello CM, Thongprayoon C, Markovic SN, Herrmann J, Otley CC, Taner T, Mangold AR, Leung N, Herrmann SM, Kukla A. Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single-center analysis. Cancer. 2020 Nov 1; 126 (21):4780-4787 Epub 2020 Aug 12
    View PubMed
  48. Herrmann SM, Alexander MP, Romero MF, Zand L. Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor-A Report of 3 Cases. Kidney Med. 2020 Sep-Oct; 2 (5):657-662 Epub 2020 Aug 11
    View PubMed
  49. Pinto E Vairo F, Pichurin PN, Fervenza FC, Nasr SH, Mills K, Schmitz CT, Klee EW, Herrmann SM. Nail-patella-like renal disease masquerading as Fabry disease on kidney biopsy: a case report. BMC Nephrol. 2020 Aug 13; 21 (1):341
    View PubMed
  50. Heybeli C, Nathan MA, Herrmann SM. Renal injury in the setting of immune checkpoint inhibitor: Report of a case of hypothyroidism and the role of positron emission tomography Journal of Onco-Nephrology. 2020.
  51. Herrmann SM, Perazella MA. Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events. Kidney Int Rep. 2020 Aug; 5 (8):1139-1148 Epub 2020 Apr 29
    View PubMed
  52. Bobart SA, Owoyemi I, Grande J, Leung N, Herrmann SM. Immune Check Point Inhibitor-Associated Endothelialitis. Kidney Int Rep. 2020 Aug; 5 (8):1371-1374 Epub 2020 June 03
    View PubMed
  53. Abumoawad A, Saad A, Ferguson CM, Eirin A, Herrmann SM, Hickson LJ, Goksu BB, Bendel E, Misra S, Glockner J, Dietz AB, Lerman LO, Textor SC. In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure. Kidney Int. 2020 Apr; 97 (4):793-804 Epub 2019 Dec 13
    View PubMed
  54. Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study. J Am Soc Nephrol. 2020 Feb; 31 (2):435-446 Epub 2020 Jan 02
    View PubMed
  55. Manohar S, Thongprayoon C, Cheungpasitporn W, Markovic SN, Herrmann SM. Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients. Kidney Int Rep. 2020 Feb; 5 (2):149-158 Epub 2019 Dec 07
    View PubMed
  56. Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, Herrmann SM, Jensen MD, Jia Q, Jordan KL, Kellogg TA, Khosla S, Koerber DM, Lagnado AB, Lawson DK, LeBrasseur NK, Lerman LO, McDonald KM, McKenzie TJ, Passos JF, Pignolo RJ, Pirtskhalava T, Saadiq IM, Schaefer KK, Textor SC, Victorelli SG, Volkman TL, Xue A, Wentworth MA, Wissler Gerdes EO, Allison DB, Dickinson SL, Ejima K, Atkinson EJ, Lenburg M, Zhu Y, Tchkonia T, Kirkland JL. Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456. EBioMedicine. 2020 Feb; 52:102595 Epub 2020 Jan 23
    View PubMed
  57. Manohar S, Ghamrawi R, Chengappa M, Goksu BNB, Kottschade L, Finnes H, Dronca R, Leventakos K, Herrmann J, Herrmann SM. Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge. Kidney360. 2020 Jan 30; 1 (1):16-24 Epub 2020 Jan 07
    View PubMed
  58. Herrmann SM, Textor SC. Renovascular Hypertension. Endocrinol Metab Clin North Am. 2019 Dec; 48 (4):765-778 Epub 2019 Sept 19
    View PubMed
  59. Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, Herrmann SM, Jensen MD, Jia Q, Jordan KL, Kellogg TA, Khosla S, Koerber DM, Lagnado AB, Lawson DK, LeBrasseur NK, Lerman LO, McDonald KM, McKenzie TJ, Passos JF, Pignolo RJ, Pirtskhalava T, Saadiq IM, Schaefer KK, Textor SC, Victorelli SG, Volkman TL, Xue A, Wentworth MA, Wissler Gerdes EO, Zhu Y, Tchkonia T, Kirkland JL. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019 Sep; 47:446-456 Epub 2019 Sept 18
    View PubMed
  60. Eirin A, Herrmann SM, Saad A, Abumoawad A, Tang H, Lerman A, Textor SC, Lerman LO. Urinary mitochondrial DNA copy number identifies renal mitochondrial injury in renovascular hypertensive patients undergoing renal revascularization: A Pilot Study. Acta Physiol (Oxf). 2019 Jul; 226 (3):e13267 Epub 2019 Mar 13
    View PubMed
  61. Abumoawad A, Saad A, Ferguson CM, Eirin A, Woollard JR, Herrmann SM, Hickson LJ, Bendel EC, Misra S, Glockner J, Lerman LO, Textor SC. Tissue hypoxia, inflammation, and loss of glomerular filtration rate in human atherosclerotic renovascular disease. Kidney Int. 2019 Apr; 95 (4):948-957
    View PubMed
  62. Kompotiatis P, Thongprayoon C, Manohar S, Cheungpasitporn W, Gonzalez Suarez ML, Craici IM, Mao MA, Herrmann SM. Association between urologic malignancies and end-stage renal disease: A meta-analysis. Nephrology (Carlton). 2019 Jan; 24 (1):65-73
    View PubMed
  63. Manohar S, Kompotiatis P, Thongprayoon C, Cheungpasitporn W, Herrmann J, Herrmann SM. Programmed cell death protein 1 inhibitor treatment is associated with acute kidney injury and hypocalcemia: meta-analysis. Nephrol Dial Transplant. 2019 Jan 1; 34 (1):108-117
    View PubMed
  64. Bian X, Griffin TP, Zhu X, Islam MN, Conley SM, Eirin A, Tang H, O'Shea PM, Palmer AK, McCoy RG, Herrmann SM, Mehta RA, Woollard JR, Rule AD, Kirkland JL, Tchkonia T, Textor SC, Griffin MD, Lerman LO, Hickson LJ. Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy. BMJ Open Diabetes Res Care. 2019; 7 (1):e000720 Epub 2019 Dec 15
    View PubMed
  65. Touyz RM, Herrmann SMS, Herrmann J. Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events. J Am Soc Hypertens. 2018 Jun; 12 (6):409-425 Epub 2018 Mar 21
    View PubMed
  66. Manohar S, Hamadah A, Herrmann SM, Textor SC. Total Renal Artery Occlusion: Recovery of Function After Revascularization. Am J Kidney Dis. 2018 May; 71 (5):748-753 Epub 2018 Feb 09
    View PubMed
  67. Vork DL, Schneekloth TD, Bartley AC, Vaughan LE, Lapid MI, Jowsey-Gregoire SG, El-Zoghby ZM, Herrmann SM, Tran CL, Albright RC, Hickson LJ. Younger Adults Initiating Hemodialysis: Antidepressant Use for Depression Associated With Higher Health Care Utilization. Mayo Clin Proc. 2018 Mar; 93 (3):321-332
    View PubMed
  68. Kim SR, Eirin A, Herrmann SMS, Saad A, Juncos LA, Lerman A, Textor SC, Lerman LO. Preserved endothelial progenitor cell angiogenic activity in African American essential hypertensive patients. Nephrol Dial Transplant. 2018 Mar 1; 33 (3):392-401
    View PubMed
  69. Herrmann SM, Textor SC. Current Concepts in the Treatment of Renovascular Hypertension. Am J Hypertens. 2018 Jan 12; 31 (2):139-149
    View PubMed
  70. Manohar S, Thongprayoon C, Cheungpasitporn W, Mao MA, Herrmann SM. Associations of rotational shift work and night shift status with hypertension: a systematic review and meta-analysis. J Hypertens. 2017 Oct; 35 (10):1929-1937
    View PubMed
  71. Saad A, Herrmann SMS, Eirin A, Ferguson CM, Glockner JF, Bjarnason H, McKusick MA, Misra S, Lerman LO, Textor SC. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis. Circ Cardiovasc Interv. 2017 Sep; 10 (9)
    View PubMed
  72. Saad A, Dietz AB, Herrmann SMS, Hickson LJ, Glockner JF, McKusick MA, Misra S, Bjarnason H, Armstrong AS, Gastineau DA, Lerman LO, Textor SC. Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease. J Am Soc Nephrol. 2017 Sep; 28 (9):2777-2785 Epub 2017 May 01
    View PubMed
  73. Saad A, Wang W, Herrmann SM, Glockner JF, Mckusick MA, Misra S, Bjarnason H, Lerman LO, Textor SC. Atherosclerotic renal artery stenosis is associated with elevated cell cycle arrest markers related to reduced renal blood flow and postcontrast hypoxia. Nephrol Dial Transplant. 2016 Nov; 31 (11):1855-1863 Epub 2016 July 29
    View PubMed
  74. Saad A, Zhu XY, Herrmann S, Hickson L, Tang H, Dietz AB, van Wijnen AJ, Lerman L, Textor S. Adipose-derived mesenchymal stem cells from patients with atherosclerotic renovascular disease have increased DNA damage and reduced angiogenesis that can be modified by hypoxia. Stem Cell Res Ther. 2016 Sep 9; 7 (1):128 Epub 2016 Sept 09
    View PubMed
  75. Wang W, Saad A, Herrmann SM, Eirin Massat A, McKusick MA, Misra S, Lerman LO, Textor SC. Changes in inflammatory biomarkers after renal revascularization in atherosclerotic renal artery stenosis. Nephrol Dial Transplant. 2016 Sep; 31 (9):1437-43 Epub 2016 Jan 29
    View PubMed
  76. Eirin A, Saad A, Tang H, Herrmann SM, Woollard JR, Lerman A, Textor SC, Lerman LO. Urinary Mitochondrial DNA Copy Number Identifies Chronic Renal Injury in Hypertensive Patients. Hypertension. 2016 Aug; 68 (2):401-10 Epub 2016 June 20
    View PubMed
  77. Herrmann SM, Saad A, Eirin A, Woollard J, Tang H, McKusick MA, Misra S, Glockner JF, Lerman LO, Textor SC. Differences in GFR and Tissue Oxygenation, and Interactions between Stenotic and Contralateral Kidneys in Unilateral Atherosclerotic Renovascular Disease. Clin J Am Soc Nephrol. 2016 Mar 7; 11 (3):458-69 Epub 2016 Jan 19
    View PubMed
  78. Antonello VS, Antonello IC, Herrmann S, Tovo CV. Proteinuria is common among HIV patients: what are we missing? Clinics (Sao Paulo). 2015 Oct; 70 (10):691-5
    View PubMed
  79. Herrmann SM, Govani MV, Fidler ME, Nasr SH, Klink D, Amin C, Leung N, Fervenza FC. Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myeloma. Clin Nephrol. 2015 Oct; 84: (4)241-6.
    View PubMed
  80. Kwon SH, Saad A, Herrmann SM, Textor SC, Lerman LO. Determination of Single-Kidney Glomerular Filtration Rate in Human Subjects by Using CT. Radiology. 2015 Aug; 276 (2):490-8 Epub 2015 Apr 06
    View PubMed
  81. Zhu XY, Ebrahimi B, Eirin A, Woollard JR, Tang H, Jordan KL, Ofori M, Saad A, Herrmann SM, Dietz AB, Textor SC, Lerman A, Lerman LO. Renal Vein Levels of MicroRNA-26a Are Lower in the Poststenotic Kidney. J Am Soc Nephrol. 2015 Jun; 26 (6):1378-88 Epub 2014 Sept 30
    View PubMed
  82. Saad A, Herrmann SM, Textor SC. Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease? Physiology (Bethesda). 2015 May; 30 (3):175-82
    View PubMed
  83. Park MY, Herrmann SM, Saad A, Eirin A, Tang H, Lerman A, Textor SC, Lerman LO. Biomarkers of kidney injury and klotho in patients with atherosclerotic renovascular disease. Clin J Am Soc Nephrol. 2015 Mar 6; 10 (3):443-51 Epub 2014 Dec 26
    View PubMed
  84. Park MY, Herrmann SM, Saad A, Widmer RJ, Tang H, Zhu XY, Lerman A, Textor SC, Lerman LO. Circulating and renal vein levels of microRNAs in patients with renal artery stenosis. Nephrol Dial Transplant. 2015 Mar; 30 (3):480-90 Epub 2014 Oct 31
    View PubMed
  85. Herrmann SM, Saad A, Textor SC. Management of atherosclerotic renovascular disease after Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL). Nephrol Dial Transplant. 2015 Mar; 30 (3):366-75 Epub 2014 Apr 09
    View PubMed
  86. Herrmann J, Herrmann SM, Haddad TC. New-onset heart failure in association with severe hypertension during trastuzumab therapy. Mayo Clin Proc. 2014 Dec; 89: (12)1734-9.
    View PubMed
  87. Chen Z, Herrmann SM, Zhu X, Jordan KL, Gloviczki ML, Lerman A, Textor SC, Lerman LO. Preserved function of late-outgrowth endothelial cells in medically treated hypertensive patients under well-controlled conditions. Hypertension. 2014 Oct; 64 (4):808-14 Epub 2014 July 21
    View PubMed
  88. Astorne Figari WJ, Herrmann S, Akogyeram C, Qian Q. New onset hypertension following abrupt discontinuation of citalopram. Clin Nephrol. 2014 Sep; 82(3):202-4.
    View PubMed
  89. Frazee EN, Rule AD, Herrmann SM, Kashani KB, Leung N, Virk A, Voskoboev N, Lieske JC. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: A cohort study. Crit. Care. 2014; 18(3):R110.
    View PubMed
  90. Eirin A, Zhu XY, Woollard JR, Herrmann SM, Gloviczki ML, Saad A, Juncos LA, Calhoun DA, Rule AD, Lerman A, Textor SC, Lerman LO. Increased circulating inflammatory endothelial cells in blacks with essential hypertension. Hypertension. 2013 Sep; 62 (3):585-91 Epub 2013 June 24
    View PubMed
  91. Saad A, Crane J, Glockner JF, Herrmann SM, Friedman H, Ebrahimi B, Lerman LO, Textor SC. Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. Radiology. 2013 Sep; 268 (3):770-8 Epub 2013 June 20
    View PubMed
  92. Saad A, Herrmann SM, Crane J, Glockner JF, McKusick MA, Misra S, Eirin A, Ebrahimi B, Lerman LO, Textor SC. Stent revascularization restores cortical blood flow and reverses tissue hypoxia in atherosclerotic renal artery stenosis but fails to reverse inflammatory pathways or glomerular filtration rate. Circ Cardiovasc Interv. 2013 Aug; 6 (4):428-35 Epub 2013 July 30
    View PubMed
  93. Gloviczki ML, Keddis MT, Garovic VD, Friedman H, Herrmann S, McKusick MA, Misra S, Grande JP, Lerman LO, Textor SC. TGF expression and macrophage accumulation in atherosclerotic renal artery stenosis. Clin J Am Soc Nephrol. 2013 Apr; 8 (4):546-53 Epub 2012 Dec 20
    View PubMed
  94. Leung N, Gertz M, Kyle RA, Fervenza FC, Irazabal MV, Eirin A, Kumar S, Cha SS, Rajkumar SV, Lacy MQ, Zeldenrust SR, Buadi FK, Hayman SR, Nasr SH, Sethi S, Ramirez-Alvarado M, Witzig TE, Herrmann SM, Dispenzieri A. Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases. Clin J Am Soc Nephrol. 2012 Dec; 7 (12):1964-8 Epub 2012 Sept 27
    View PubMed
  95. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, Tang H, Herrmann SM, Lerman A, Textor SC, Lerman LO. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension. 2012 Nov; 60 (5):1242-9 Epub 2012 Oct 08
    View PubMed
  96. Herrmann SM, Textor SC. Diagnostic criteria for renovascular disease: where are we now? Nephrol Dial Transplant. 2012 Jul; 27 (7):2657-63
    View PubMed
  97. Keddis M, Leung N, Herrmann S, El-Zoghby Z, Sethi S. Adenovirus-induced interstitial nephritis following umbilical cord blood transplant for chronic lymphocytic leukemia. Am J Kidney Dis. 2012 Jun; 59 (6):886-90 Epub 2012 Mar 08
    View PubMed
  98. Herrmann SM, Sethi S, Fervenza FC. Membranous nephropathy: the start of a paradigm shift. Curr Opin Nephrol Hypertens. 2012 Mar; 21 (2):203-10
    View PubMed
  99. Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP, Herrmann S, Tefferi A, D'Agati VD, Nasr SH. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int. 2011 Oct; 80(7):753-9. Epub 2011 Jun 8
    View PubMed
  100. Herrmann SM, Gertz MA, Stegall MD, Dispenzieri A, Cosio FC, Kumar S, Lacy MQ, Dean PG, Prieto M, Zeldenrust SR, Buadi FK, Russell SJ, Nyberg SL, Hayman SR, Dingli D, Fervenza FC, Leung N. Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant. 2011 Jun; 26(6):2032-6. Epub 2011 May 4
    View PubMed
  101. Sethi S, Zand L, Leung N, Smith RJ, Jevremonic D, Herrmann SS, Fervenza FC. Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy. Clin J Am Soc Nephrol. 2010 May; 5 (5):770-82 Epub 2010 Feb 25
    View PubMed
  102. Soares SM, Fervenza FC, Lager DJ, Gertz MA, Cosio FG, Leung N. Bleeding complications after transcutaneous kidney biopsy in patients with systemic amyloidosis: single-center experience in 101 patients. Am J Kidney Dis. 2008 Dec; 52(6):1079-83. Epub 2008 Jul 23
    View PubMed
  103. Herrmann J, Soares SM, Lerman LO, Lerman A. Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease. J Am Coll Cardiol. 2008 May 27; 51: (21)2003-10.
    View PubMed
  104. Barbosa MT, Soares SM, Novak CM, Sinclair D, Levine JA, Aksoy P, Chini EN. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 2007 Nov; 21(13):3629-39. Epub 2007 Jun 21.
    View PubMed
  105. Soares S, Thompson M, White T, Isbell A, Yamasaki M, Prakash Y, Lund FE, Galione A, Chini EN. NAADP as a second messenger: neither CD38 nor base-exchange reaction are necessary for in vivo generation of NAADP in myometrial cells. Am J Physiol Cell Physiol. 2007 Jan; 292 (1):C227-39 Epub 2006 June 21
    View PubMed
  106. Aksoy P, Escande C, White TA, Thompson M, Soares S, Benech JC, Chini EN. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem Biophys Res Commun. 2006 Oct 13; 349 (1):353-9 Epub 2006 Aug 22
    View PubMed
  107. Soares SM, Sethi S. Impairment of renal function after intravenous immunoglobulin. Nephrol Dial Transplant. 2006 Mar; 21(3):816-7. Epub 2006 Jan 06.
    View PubMed
  108. Soares SM, Lager DJ, Leung N, Haugen EN, Fervenza FC. A proliferative glomerulonephritis secondary to a monoclonal IgA. Am J Kidney Dis. 2006 Feb; 47(2):342-9.
    View PubMed
  109. Soares SM, Thompson M, Chini EN. Role of the second-messenger cyclic-adenosine 5'-diphosphate-ribose on adrenocorticotropin secretion from pituitary cells. Endocrinology. 2005 May; 146 (5):2186-92 Epub 2005 Feb 17
    View PubMed
PST-20216293